Contains no artificial colours, preservatives, or sweeteners; no dairy, starch, sugar, wheat, gluten, yeast, soy, egg, fish, shellfish, salt, tree nuts, or GMOs. Suitable for vegetarians. Sealed for your protection. Do not use if seal is broken. For freshness, store in a cool, dry place.
Drug Interactions
Although NAC may reduce nitroglycerin tolerance and improve its efficacy for unstable angina, severe headaches and hypotension may occur. Bromelain may increase the concentration of several antibiotics and should be used with caution in patients on anticoagulants. Marshmallow may have a hypoglycemic effect and should be used with caution with antidiabetic medications.
References
1. Sutherland, E. R., Crapo, J. D., & Bowler, R. P. (2006). N-acetylcysteine and exacerbations of chronic obstructive pulmonary disease.
COPD, 3(4), 195-202.
2. Demedts, M., Behr, J., Buhl, R., et al., for the IFIGENIA Study Group. (2005). High-dose acetylcysteine in idiopathic pulmonary fibrosis.
New England Journal of Medicine, 353(21), 2229-2242.
3. Aldini, G., Altomare, A., Baron, G., et al. (2018). N-Acetylcysteine as an antioxidant and disulphide breaking agent: the reasons why. Free Radical Research, 52(7), 751-762.
4. Mokhtari, V., Afsharian, P., Shahhoseini, M., et al. (2017). A review on various uses of N-Acetyl Cysteine.
Cell Journal, 19(1), 11-17.
5. Qi, Q., Ailiyaer, Y., Liu, R., et al. (2019). Effect of N-acetylcysteine on exacerbations of bronchiectasis (BENE): a randomized controlled trial.
Respiratory Research, 20(1), 73.
6. Zheng, J. P., Wen, F. Q., Bai, C. X., et al. (2014). Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial.
Lancet Respiratory Medicine, 2(3), 187-194.
7. Palacio, J. R., Markert, U. R., & Martínez, P. (2011). Anti-inflammatory properties of N-acetylcysteine on lipopolysaccharide-activated macrophages.
Inflammation Research, 60(7), 695-704.
8. Zafarullah, M., Li, W. Q., Sylvester, J., et al. (2003). Molecular mechanisms of N-acetylcysteine actions.
Cellular and Molecular Life Sciences, 60(1), 6-20.
9. De Flora, S., Grassi, C., & Carati, L. (1997). Attenuation of influenza-like symptomatology and improvement of cell-mediated immunity with long-term N-acetylcysteine treatment.
European Respiratory Journal, 10(7), 1535-1541.
10. Zuhra, K., Tomé, C. S., Masi, L., et al. (2019). N-Acetylcysteine serves as substrate of 3-Mercaptopyruvate sulfurtransferase and stimulates sulfide metabolism in colon cancer cells.
Cells, 8(8), 828.
11. Braun, J. M., Schneider, B., & Beuth, H. J. (2005). Therapeutic use, efficiency and safety of the proteolytic pineapple enzyme Bromelain-POS in children with acute sinusitis in Germany.
In Vivo, 19(2), 417-421.
12. Deters, A., Zippel, J., Hellenbrand, N., et al. (2010). Aqueous extracts and polysaccharides from Marshmallow roots (Althea officinalis L.): cellular internalisation and stimulation of cell physiology of human epithelial cells in vitro.
Journal of Ethnopharmacology, 127(1), 62-69.
13. Cwientzek, U., Ottillinger, B., & Arenberger, P. (2011). Acute bronchitis therapy with ivy leaves extracts in a two-arm study. A double-blind, randomised study vs. another ivy leaves extract.
Phytomedicine, 18(13), 1105-1109.
14. Zeil, S., Schwanebeck, U., & Vogelberg, C. (2014). Tolerance and effect of an add-on treatment with a cough medicine containing ivy leaves dry extract on lung function in children with bronchial asthma. Phytomedicine, 21(10), 1216-1220.
15. Turker, A. U., & Gurel, E. (2005). Common mullein (Verbascum thapsus L.): recent advances in research.
Phytotherapy Research, 19(9), 733-739.